References
- Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 1978; 3: 128–143
- Westenberg H. G.M. Bioanalysis and pharmacokinetics of carbamazepine. University of Groningen, The Netherlands 1980, PhD-thesis
- Gruska H., Beyer K.-H., Kubicki S., Schneider H., Klinik. Toxikologie und Therapie einer schweren Carbamazepin-Vergiftung. Arch. Toxicol. 1971; 27: 193–203
- Guelzow H.-U., Gottschall S., Heín J. Ueber eine Intoxikation mit Karbamazepin und Diphenylhydantoin im Kindesalter. Kinderaertzl. Prax. 1975; 43: 62–66
- Saloman M., Pippenger CE. Acute carbamazepine encephalopathy. J.A.M.A. 1975; 231: 915
- De Zeeuw R. A., Westenberg H. G.M., Van der Kleijn E. J. S., Gimbrere F. An unusual case of carbamazepine poisoning with a near-fatal relapse after two days. Clin. Toxicol. 1979; 14: 263–269
- Chan K.-M., Aguanno J. J., Jansen R., Dietzler D. N. Charcoal hemoperfusion for treatment of carbamazepine poisoning. Clin. Chem. 1981; 27: 1300–1302
- Faigle J. W., Feldmann K. F., Baltzer V. Anticonvulsant effect of carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite. Anti-epileptic drug monitoring, C. Gardner-Thorpe, D. Janz, H. Meinardi, C. E. Pippenger. Pitman Press, Avon 1977; 104–109
- Eichelbaum M., Ekbom K., Bertilsson L., Ringberger V. A., Rane A. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur. J. Clin. Pharmacol. 1975; 8: 337–341
- Rane A., Hojer B., Wilson J. T. Kinetics of carbamazepine and its 10,11,-epoxide metabolite in children. Clin. Pharmacol. Ther. 1976; 19: 276–283
- De Groot G. Haemoperfusion in clinical toxicology. A pharmacokinetic evaluation. University of Utrecht, The Netherlands 1982, PhD-thesis
- Westenberg H. G.M., Van der Kleijn E., Oei T. T., De Zeeuw R. A. Kinetics of carbamazepine and carbamazepine-epoxide determined by use of plasma and saliva. Clin. Pharmacol. Ther. 1978; 23: 320–328
- Rawlins M. D., Collste P., Bertllsson L., Palmer L. Distribution and elimination kinetics of carbamazepine in man. Eur. J. Clin. Pharmacol. 1975; 8: 91–96
- Pynnonen S. The pharmacokinetics of carbamazepine in plasma and saliva of man. Acta Pharmacol. Toxicol. 1977; 41: 465–471
- Paxton J. W., Donald R. A. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum. Clin. Pharmacol. Ther. 1980; 28: 695–702
- Tomson T., Tybring G., Bertllsson L. Single-dose kinetics and metabolism of carbamazepine-10,ll-epoxide. Clin. Pharmacol. Ther. 1983; 33: 58–65
- Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbital, carbamazepine and phenylbutazone in man. Eur. J. Clin. Pharmacol. 1980; 17: 51–57
- Faigle J. W., Feldmann K. F. Pharmacokinetic data of carbamazepine and its major metabolites in man. Clinical pharmacology of anti-epileptic drugs, H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin. Springer, Berlin, Heidelberg, New York 1975; 159–165
- Lee C. S., Wang L. H., Marbury T. C., Bruni J., Perchalski R. J. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis. Clin. Toxicol. 1980; 17: 429–438
- Hooper W. D., Dubetz D. K., Bochner F., Cotter L. M., Smith G. A., Eadie M. J., Tyrer J. H. Plasma protein binding of carbamazepine. Clin. Pharmacol. Ther. 1975; 17: 433–440
- Pynnonen S., Yrjana T. The significance of the simultaneous determination of carbamazepine and its 10,11-epoxide from plasma and human erythrocytes. Int. J. Clin. Pharmacol. 1977; 15: 222–226